Development Level

Tbio 4 | 10,625
Tchem 2 | 1,890

Disease

Cancer 5 | 2,346
lung adenocarcinoma 4 | 2,713
pancreatic cancer 4 | 2,300
psoriasis 4 | 6,685
Breast cancer 3 | 3,094
Kidney disease 3 | 396
Pick disease 3 | 1,893
Reperfusion Injury 3 | 84
esophageal adenocarcinoma 3 | 737
interstitial cystitis 3 | 2,299
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 3 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,289
invasive ductal carcinoma 3 | 2,950
medulloblastoma, large-cell 3 | 6,234
non-small cell lung cancer 3 | 2,798
osteosarcoma 3 | 7,933
ovarian cancer 3 | 8,484
ulcerative colitis 3 | 2,087
Alzheimer's disease 2 | 644
Anemia 2 | 252
Autistic Disorder 2 | 320
Carcinoma 2 | 2,147
Duchenne muscular dystrophy 2 | 602
Eye disease 2 | 55
Hemochromatosis 2 | 55
Inflammation 2 | 109
Iron deficiency anemia 2 | 6
Iron metabolism disease 2 | 17
Malaria 2 | 140
Mammary Neoplasms 2 | 410
Neoplasm Invasiveness 2 | 127
Neoplastic Cell Transformation 2 | 81
Obesity 2 | 616
Severe Combined Immunodeficiency 2 | 46
Thalassemia 2 | 46
astrocytic glioma 2 | 2,241
atypical teratoid/rhabdoid tumor 2 | 1,095
cutaneous lupus erythematosus 2 | 1,056
diabetes mellitus 2 | 1,663
ductal carcinoma in situ 2 | 1,745
gastric carcinoma 2 | 832
glioblastoma 2 | 5,572
hepatocellular carcinoma 2 | 532
lung cancer 2 | 4,466
malignant mesothelioma 2 | 3,162
oligodendroglioma 2 | 2,849
pituitary cancer 2 | 1,972
posterior fossa group B ependymoma 2 | 1,530
primary pancreatic ductal adenocarcinoma 2 | 1,271
primitive neuroectodermal tumor 2 | 3,031
progressive supranuclear palsy 2 | 674
subependymal giant cell astrocytoma 2 | 2,287
Adenocarcinoma 1 | 115
Alcohol dependence 1 | 107
Alcoholic Intoxication, Chronic 1 | 41
Animal Mammary Neoplasms 1 | 136
Bladder Neoplasm 1 | 109
Brain disease 1 | 83
Chronic Lymphocytic Leukemia 1 | 242
Cleft palate 1 | 125
Colorectal Neoplasms 1 | 217
Congenital disorder of glycosylation 1 | 53
Disease Progression 1 | 125
Drug-Induced Liver Injury 1 | 118
Fatty Liver 1 | 48
Fatty liver disease 1 | 84
Glaucoma 1 | 134
Glioma 1 | 65
Gout 1 | 93
Heart disease 1 | 279
Helicobacter Infections 1 | 5
Hepatitis B 1 | 103
Hepatitis C 1 | 90
Inflammatory bowel disease 1 | 142
Kidney Diseases 1 | 86
Liver carcinoma 1 | 217
Liver disease 1 | 219
Lung Neoplasms 1 | 171
Lung disease 1 | 132
Lymphoma, Non-Hodgkin 1 | 22
Mammary Neoplasms, Experimental 1 | 150
Meningitis 1 | 46
Neoplasm Metastasis 1 | 138
Neurodegenerative disease 1 | 383
Osteoarthritis 1 | 96
Osteoporosis 1 | 257
Parkinson's disease 1 | 364
Peripheral vascular disease 1 | 90
Polycystic kidney disease 1 | 54
Proteinuria 1 | 63
Vitamin B12 deficiency 1 | 20
cystic fibrosis and chronic rhinosinusitis 1 | 213
glioblastoma multiforme 1 | 347
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
interstitial lung disease 1 | 291
non-inflammatory breast cancer 1 | 208
protein-losing enteropathy 1 | 11
sarcoidosis 1 | 358
substance-related disorder 1 | 105

Tissue

Digestive Tract 6 | 18,473
Endocrine System 6 | 18,512
Female tissues 6 | 18,647
Liver and Pancreas 6 | 18,136
Male tissues 6 | 17,969
Nervous System 6 | 18,561
Respiratory system 6 | 17,484
Skin and soft tissues 6 | 18,115
Urinary Tract 6 | 18,444
Blood and immune system 5 | 17,995
Cardiovascular System 5 | 17,958

Target Family

Non-IDG 6 | 11,971

Grant Application

5R01GM079542-02 6 | 6
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Serotransferrin TF Tchem Non-IDG -4.13136 13124.3 952
Transferrin receptor protein 1 TFRC Tbio Non-IDG -3.39868 2437.0 1167
Pro-epidermal growth factor EGF Tbio Non-IDG -3.74376 4837.7 851
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.26799 140.7 401
Protein Wnt-3a WNT3A Tchem Non-IDG -2.66796 428.8 301
Thy-1 membrane glycoprotein THY1 Tbio Non-IDG -3.24023 1666.5 1095